Markets.com Logo

TOUR

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.7705$
  • Previous Close
    0.8502$
  • 52 Week Change
    0.98$
  • Day Range
    -0.08$
  • 52 Week High/Low
    0.7208$ - 1.7005$
  • Dividend Per Share
    0.0427
  • Market cap
    97 926 K$
  • EPS
    -0.03
  • Beta
    1.672
  • Volume
    --

About

Tours.com, Inc. (TOUR.US) operates an online platform focused on travel and tourism-related information and services. The company's platform provides access to travel guides, maps, hotel information, tour packages, and other resources intended to assist users in planning and booking travel experiences. Their business model centers around advertising revenue generated from travel-related companies and commissions earned from facilitating bookings.

Fed Policy at Crossroads: Geopolitical Shocks and Inflationary Pressures

Sophia Claire|--

Wall Street Strategists Maintain Bullish Stance on US Equities Amidst Geopolitical Risks

Noah Lee|--

Analyzing Iran War Duration: A Formula for Conflict Prediction

Noah Lee|--

Iran Holds the Key to Global Energy Restart Amidst Middle East Crisis

Liam James|--

Bank of America Raises 2026 Brent Crude Forecast Amidst Hormuz Strait Disruptions

Sophia Claire|--
Commodity market analysis: What factors could influence gold prices (XAU/USD)?

Commodity market analysis: What factors could influence gold prices (XAU/USD)?

Frances Wang|--
DFM and ADX High-Volume Stock Movers: Emaar Properties (EMAAR), Emirates NBD, Salik

DFM and ADX High-Volume Stock Movers: Emaar Properties (EMAAR), Emirates NBD, Salik

Ghko B|--

Factors

Company Performance: Tourmaline Bio's financial health, including revenue, profit margins, and clinical trial results, directly impacts investor confidence and stock price.

Market Sentiment: Overall investor mood towards the biotechnology sector and small-cap stocks influences demand and price.

Competition: Success or failure of competitor drugs in the same therapeutic area (like inflammatory bowel disease) can shift market share expectations.

Regulatory Approval: FDA decisions on Tourmaline Bio's drug candidates are major catalysts, as approval significantly increases the company's value.

Economic Conditions: Macroeconomic factors, such as interest rates and inflation, can affect investor risk appetite and capital flows into biotech stocks.

Partnerships & Acquisitions: News of potential collaborations or acquisitions can boost the stock price, reflecting increased potential for growth.

Clinical Trial Data: Positive or negative results from clinical trials are crucial for investor perception of the drug's efficacy and safety.

Management Team: The experience and reputation of Tourmaline Bio's management team can influence investor confidence.

News and Media Coverage: Media reports and analyst ratings can sway investor sentiment and affect trading volume.

Stock Dilution: Issuance of new shares (stock dilution) can decrease the value of existing shares, potentially lowering the price.

People Also Watch

Latest news

Retail Investors Flood into Oil Amid Global Energy Market Turmoil

Ava Grace|--

Ukraine Peace Talks Nearing Stalemate Amid Shifting US Focus to Iran Conflict

Sophia Claire|--

Fed Nominee Warsh Confirmation Delayed Amidst Financial Scrutiny and Political Hurdles

Sophia Claire|--

Latest Education Articles

How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

Ghko B|--
Crypto trading for beginners: How to trade Bitcoin (BTC/USD) in UAE & Dubai?

Crypto trading for beginners: How to trade Bitcoin (BTC/USD) in UAE & Dubai?

Ghko B|--
Gold prices today in the UAE: How to begin investing in gold in the UAE?

Gold prices today in the UAE: How to begin investing in gold in the UAE?

Ghko B|--